KIDS Orthopediatrics Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: KIDS

Price (delayed)

$22.33

Market cap

$583.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.68

Enterprise value

$667.67M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 37

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on providing a comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. ...

Highlights
The gross profit has increased by 18% year-on-year and by 4.7% since the previous quarter
The revenue rose by 14% year-on-year and by 3.9% since the previous quarter
KIDS's debt is up by 6% year-on-year but it is down by 2.4% since the previous quarter
The quick ratio has contracted by 37% YoY and by 8% from the previous quarter
The equity has declined by 3.3% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.orthopediatrics.com
Peers: OFIX

Key stats

What are the main financial stats of KIDS

KIDS stock price

How has the Orthopediatrics stock price performed over time
Intraday
-1.89%
1 week
-3.54%
1 month
-12.94%
1 year
17.9%
YTD
25.73%
QTD
16.73%

Financial performance

How have Orthopediatrics's revenue and profit performed over time
Revenue
$252.73M
Gross profit
$186.14M
Operating income
-$30M
Net income
-$39.73M
Gross margin
73.7%
Net margin
-15.7%
KIDS's operating margin is up by 36% year-on-year and by 21% since the previous quarter
Orthopediatrics's operating income has increased by 27% YoY and by 18% QoQ
The gross profit has increased by 18% year-on-year and by 4.7% since the previous quarter
KIDS's net margin is up by 17% year-on-year and by 3.7% since the previous quarter

Price vs fundamentals

How does KIDS's price correlate with its fundamentals

Growth

What is Orthopediatrics's growth rate over time

Valuation

What is Orthopediatrics stock price valuation
P/E
N/A
P/B
1.67
P/S
2.12
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.64
The EPS is up by 7% year-on-year
The price to book (P/B) is 32% less than the 5-year quarterly average of 2.5 but 31% more than the last 4 quarters average of 1.3
The equity has declined by 3.3% year-on-year
KIDS's price to sales (P/S) is 61% lower than its 5-year quarterly average of 5.5 but 21% higher than its last 4 quarters average of 1.8
The revenue rose by 14% year-on-year and by 3.9% since the previous quarter

Efficiency

How efficient is Orthopediatrics business performance
KIDS's ROIC is up by 31% YoY and by 5% from the previous quarter
The return on sales is up by 31% year-on-year and by 8% since the previous quarter
The return on assets is up by 8% year-on-year

Dividends

What is KIDS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KIDS.

Financial health

How did Orthopediatrics financials performed over time
The quick ratio has contracted by 37% YoY and by 8% from the previous quarter
Orthopediatrics's current ratio has decreased by 28% YoY and by 8% QoQ
KIDS's debt is 70% smaller than its equity
The debt to equity has grown by 7% YoY but it has contracted by 3.2% from the previous quarter
KIDS's debt is up by 6% year-on-year but it is down by 2.4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.